Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TM-400 receives FDA orphan drug status

July 27, 2011

TH-302 and bevacizumab enter clinical trial in astrocytoma

July 27, 2011

Hutchison MediPharma patents new HGF receptor inhibitors

July 27, 2011

EMA recommends orphan drug status for 4SC's resminostat

July 26, 2011

Orally active histone deacetylase inhibitor displays potent antitumor activity in vivo

July 26, 2011

New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato

July 26, 2011

Novartis claims novel agents for treatment of cancer

July 26, 2011

CHMP issues opinion on Zytiga in prostate cancer

July 25, 2011

Afinitor recommended for new European approval

July 25, 2011

Tarceva recommended for E.U. approval as first-line therapy in distinct type of lung cancer

July 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...